000			02118 a2200589 4500
005			20250517212117.0
264		0	_c20190108
008			201901s 0 0 eng d
022			_a2210-7762
024	7		_a10.1016/j.cancergen.2018.01.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aAdams, Thomas
245	0	0	_aUnexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci. _h[electronic resource]
260			_bCancer genetics _c04 2018
300			_a25-31 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aChromosome Inversion
650	0	4	_aChromosomes, Human, Pair 18 _xgenetics
650	0	4	_aChromosomes, Human, Pair 3 _xgenetics
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGene Expression Profiling
650	0	4	_aGene Order
650	0	4	_aGenes, myc
650	0	4	_aHumans
650	0	4	_aIn Situ Hybridization, Fluorescence
650	0	4	_aLymphoma, B-Cell _xdrug therapy
650	0	4	_aMDS1 and EVI1 Complex Locus Protein _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Grading
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aProto-Oncogene Proteins c-bcl-6 _xgenetics
650	0	4	_aProto-Oncogene Proteins c-myc _xgenetics
650	0	4	_aRemission Induction
650	0	4	_aSequence Analysis, RNA
650	0	4	_aTranslocation, Genetic
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xtherapeutic use
700	1		_aFuchs, Deborah
700	1		_aShadoan, Patricia K
700	1		_aJohnstone, Laurel
700	1		_aLau, Branden M
700	1		_aMcGhan, Lee
700	1		_aAnwer, Faiz
700	1		_aAl-Kateb, Hussam
773	0		_tCancer genetics _gvol. 222-223 _gp. 25-31
856	4	0	_uhttps://doi.org/10.1016/j.cancergen.2018.01.003 _zAvailable from publisher's website
999			_c28297821 _d28297821